With superstar CEO, new CRISPR company targets heart disease - STAT
La 'forma a mela': perchè si accumula il grasso sulla pancia?
Sekar Kathiresan – Relay Therapeutics
Sekar Kathiresan M.D. | Verve Therapeutics
Gene-editing startup Verve Therapeutics raises $58M from Google Ventures and others - Philadelphia Business Journal
CAN SEKAR KATHIRESAN KILL HEART ATTACKS?
Sekar Kathiresan, MD: American Heart Association Distinguished Scientist - Mass General Advances in Motion
Can Sekar Kathiresan kill heart attacks? | Mint
Sekar Kathiresan: Why Are Polygenic Risk Scores Important?
ASHG Honors Sekar Kathiresan with 2018 Curt Stern Award - ASHG
Verve CEO Interview: Gene Editing for Heart Disease, New Data
Can Sekar Kathiresan (@sekar.kathiresan) rewrite the story of heart attacks? 🧬🚀 Dive into the groundbreaking world of gene editing for… | Instagram
Sekar Kathiresan: How early in life does a genetic predisposition to obesity become obvious?
Sekar Kathiresan | KCRW
Sekar Kathiresan | Sekar Kathiresan | Broad Institute
Role of Genes, Lifestyle Explored in Heart Attack | NIH Record
Kathiresan and Topol on Genomics of Heart Disease
Sekar Kathiresan, M.D. | All of Us Research Program | NIH
Vertex Collaborates with Verve to Discover and Develop an In Vivo Gene Editing Program for Liver Disease - Global Genes
Heart attacks struck Sek Kathiresan's family. He's devoted his life to stopping them. | BioPharma Dive
